Company intelligence / Profile preview

Thimble Bioelectronics

San Francisco, California, United States

Ownership: Private
Development stage: Preclinical

Overview

The company developed a wearable TENS device ("CUR Model 1"/"Enso") for chronic and acute musculoskeletal pain. It received FDA clearance in 2016 and was evaluated in at least two clinical trials. The product offered app-based control and tracking but efficacy of TENS for some indications remains debated.[5][7][8] Acquired by Hinge Health in early 2021 to expand digital musculoskeletal care offerings.[9]

Therapeutic areas: RheumatologyNeurology
Modalities: DeviceNon-pharmacological therapy (Transcutaneous Electrical Nerve Stimulation - TENS)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Thimble Bioelectronics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thimble Bioelectronics.

Explore the full profile